Roche And Recursion’s AI Drug Discovery Pact To Focus On Neuroscience
Another Boost For AI
The 10-year deal aims to use artificial intelligence to map out the cellular biology behind neuroscience and oncology and accelerate drug discovery in another boost to the field.
